Friday, July 10, 2026

pharma · Sickle Cell Disease

theravia

theravia clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

FR HQ
2023 Founded
34 Employees
EMA registrant Type
Company details
Status
Public
HQ
FR
Founded
2023
Employees
34
Programs
1
Drugs
4
Patents
0
Intelligence · Clinical Programs

theravia projects

1 ClinicalTrials.gov programs sponsored by theravia.

theravia has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. SIKLOS PAEDIATRIC 50mg dispersible tablets

    THERAVIA

    Sickle Cell Disease

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does theravia have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.